Skip to the page

Data / Form D filings / Dev4 LLC

Dev4 LLC: Form D filing

Dev4 LLC, a biotechnology company in Houston, TX, filed a Form D with the SEC in 2025. The latest, on September 5, 2025, reports $1.5 million sold of a $2 million offering to 27 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1002 GEMINI STREET, SUITE 129, Houston, TX, 77058
Phone
(346) 340-4197
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2083767

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 5, 2025New notice$2,000,000$1,547,500$452,50027Aug 26, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Arnold-Peter WeissExecutive Officer, Director
Lance TerrillExecutive Officer
Stephanie PadillaExecutive Officer
Jeff SeaveyExecutive Officer, Director

Other biotechnology companies in Texas that filed recently

Every Form D from the week of Sep 1, 2025 · All recent filings in Texas · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Dev4 LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.